Anxiety Disorder News and Research

RSS

RACGP urging the government to restore mental health rebates

In its submission to the Senate Standing Committee on Community Affairs regarding the Commonwealth funding and administration of mental health services, the Royal Australian College of General Practitioners (RACGP) strongly argued for the restoration of GP mental health services. The College is gravely concerned regarding the proposed cuts to the Better Access program and the subsequent impact on mental health delivery for every patient age group, demographic and geography throughout Australia.

3 Aug 2011

Gender-based violence may increase lifetime prevalence of mental disorders in women

Women who reported experiencing gender-based violence, such as rape, sexual assault, intimate partner violence and stalking, had an associated higher lifetime prevalence of mental health disorders, dysfunction and disability, according to a study in the August 3 issue of JAMA, a theme issue on violence and human rights.

3 Aug 2011

Gender based violence can lead to long term mental ailments in women: Study

According to new research, women who are victims of violence at the hands of men are highly likely to suffer mental disorders for the rest of their lives.

3 Aug 2011

Cognitive behavioral therapy and self-help may improve unexplained symptoms of pain, fatigue

A new type of therapy may help people with symptoms such as pain, weakness, or dizziness that can't be explained by an underlying disease, according to a study published in the July 27, 2011, online issue of Neurology, the medical journal of the American Academy of Neurology.

28 Jul 2011

Interpersonal relationships in individuals with generalized anxiety disorder: Study

Most people worry from time to time. A new research study, led by a Case Western Reserve University faculty member in psychology, also shows that worrying can be so intrusive and obsessive that it interferes in the person's life and endangers the health of social relationships.

27 Jul 2011

Researchers at Macquarie trial new program to help improve neglected area of aged care

In a world first, researchers at the Centre for Emotional Health, Macquarie University are developing psychological treatments, which simultaneously target both anxiety and depression in older adults. Despite the fact that symptoms of anxiety and depression are typically suffered together, no program currently exists which is aimed at helping older adults tackle both disorders at once.

21 Jul 2011

Groundbreaking study on treatment of separation anxiety disorder

A group of Swiss researchers headed by Prof. Sylvia Schneider has published a groundbreaking study on treatment of separation anxiety in the current issue of Psychotherapy and Psychosomatics.

12 Jul 2011

Urban dwellers at greater risk of mental illness: Study

A new study shows that living in a city increases the risk of developing a mental disorder, including depression and schizophrenia, compared to people who live in non-urban areas. The findings of the has implications for around half of the world's population who live in cities.

23 Jun 2011

FDA approves Mylan's ANDA for Venlafaxine HCl ER Capsules to treat depressive, anxiety disorder

Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for Venlafaxine Hydrochloride Extended-release Capsules, 37.5 mg (base), 75 mg (base) and 150 mg (base), the generic version of Wyeth's Effexor XR Capsules, which are used in the treatment of major depressive disorder and social anxiety disorder.

3 Jun 2011

PTSD occurs with significant frequency in civilian patients after traumatic event involving physical injury

Although most commonly associated with military combat, post-traumatic stress disorder (PTSD) can occur in civilians, too - and with consequences that are just as serious, according to a new review article in the Journal of the American Academy of Orthopaedic Surgeons (JAAOS). PTSD is a type of anxiety disorder that occurs after a person experiences a traumatic event involving physical injury, and occurs in 20 to 51 percent of patients with an orthopaedic injury.

9 May 2011

Ideal psychotropic drug may cause physical dependence

A report in the current issue of Psychotherapy and Psychosomatics by a group of European investigators headed by Fabrizio Schifano has explored the potential for dependence of pregabalin using patients' online reports.

9 May 2011

Scientists discover critical pathway in the brain linked to stress response

A team of neuroscientists at the University of Leicester, UK, in collaboration with researchers from Poland and Japan, has announced a breakthrough in the understanding of the 'brain chemistry' that triggers our response to highly stressful and traumatic events.

21 Apr 2011

Forest Labs fourth quarter net sales increase 9.7% to $1,091.9 million

Forest Laboratories, Inc., an international pharmaceutical manufacturer and marketer, announced that reported earnings per share equaled $1.12 in the fourth quarter of fiscal 2011.

19 Apr 2011

Mexican-born migrants may face high risk of developing depressive, anxiety disorders

People who migrate to the United States from Mexico have a significantly higher risk of developing depressive or anxiety disorders than family members of migrants who remain in Mexico, according to a report in the April issue of Archives of General Psychiatry, one of the JAMA/Archives journals.

5 Apr 2011

Medical expert says PSTD cases may increase following Japanese tsunami

The Japanese tsunami took quite a massive toll, injuring and killing thousands and causing billions of dollars in destruction. But looking beyond physical destruction, the tsunami took an emotional toll on many as well.

29 Mar 2011

AssureRx closes $11 million Series B financing

AssureRx Health, Inc. today announced the closing of an $11 million Series B financing. The personalized medicine company, which provides clinically-relevant information to help physicians select the right drug and the right dose for individual neuropsychiatric patients, will use the funds to expand direct sales and marketing for its first product, GeneSightRx®, and for second generation product development activities.

25 Mar 2011

Videoconferencing can treat individuals with OCD

The National Institute of Mental Health estimates that one in four Americans suffer from an anxiety disorder, and of those more than 2.2 million people with anxiety disorders have obsessive compulsive disorder.

17 Mar 2011

Forest Laboratories third quarter net sales increase 6.7% to $1,063.9 million

Forest Laboratories, Inc., an international pharmaceutical manufacturer and marketer, announced that reported earnings per share equaled $1.11 in the third quarter of fiscal 2011 after taking a charge for a new product licensing fee of $66.1 million or $0.23 per share, net of tax.

18 Jan 2011

7,8-Dihydroxyflavone holds potential for treatment of fear based disorders

Living a traumatic experience favours the persistence of fear associated with an aversive stimulus, known as fear conditioning and such effect, in mice, can be suppressed with a single dosis of 7,8-Dihydroxyflavone, a type of flavonoid which boosts the ability to acquire new emotional learnings.

13 Jan 2011

95.6% of WTC survivors report posttraumatic stress symptoms

Nearly 10 years after the greatest human-made disaster in U.S. history-- the destruction of the World Trade Center (WTC) towers -- there has been little research documenting the attacks' consequences among those most directly affected -- the survivors who escaped the World Trade Center towers.

10 Jan 2011